Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $6 | $9 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $4 | $4 | $2 | $0 |
| Enterprise Value | $8 | $8 | $9 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -89.8% | – |
| Gross Profit | -$1 | -$1 | -$2 | -$0 |
| % Margin | – | – | -14,245.2% | -67.8% |
| EBITDA | -$1 | -$2 | -$2 | -$1 |
| % Margin | – | – | -19,763.4% | -598.4% |
| Net Income | -$2 | -$3 | -$2 | -$1 |
| % Margin | – | – | -13,695.1% | -646.5% |
| EPS Diluted | -0.35 | -0.52 | -0.34 | -0.13 |
| % Growth | 32.7% | -52.9% | -161.5% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | -$1 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$1 |